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Abstract
Background: Mortality rates associated with postoperative peritonitis or haemorrhage secondary to
pancreatic fistula (PF) after pancreaticoduodenectomy (PD) remain high. This study analysed the results
of an alternative management strategy for these life-threatening complications.
Methods: All patients undergoing PD between January 2004 and April 2011 were identified. Patients
who underwent further laparotomy for failure of the pancreatico-digestive anastomosis were identified.
Since 2004, this problem has been managed by dismantling the pancreatico-digestive anastomosis and
canulating the pancreatic duct remnant with a thin polyethylene tube (Escat tube), which is then passed
through the abdominal wall. Main outcome measures were mortality, morbidity and longterm outcome.
Results: From January 2004 to April 2011, 244 patients underwent a PD. Postoperatively, 21 (8.6%)
patients required re-laparotomy to facilitate a wirsungostomy. Two patients were transferred from another
hospital with life-threatening PF after PD. Causes of re-laparotomy were haemorrhage (n = 12), peritonitis
(n = 4), septic shock (n = 4) and mesenteric ischaemia (n = 1). Of the 21 patients who underwent
wirsungostomy, six patients subsequently died of liver failure (n = 3), refractory septic shock (n = 2) or
mesenteric ischaemia (n = 1) and nine patients suffered complications. The median length of hospital stay
was 42 days (range: 34–60 days). The polyethylene tube at the pancreatic duct was removed at a median
of 4 months (range: 2–11 months). Three patients developed diabetes mellitus during follow-up.
Conclusions: These data suggest that preservation of the pancreatic remnant with wirsungostomy has
a role in the management of patients with uncontrolled haemorrhage or peritonitis after PF.
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Introduction
Among experienced centres, mortality rates after pancreati-
coduodenectomy (PD) have decreased to <5% over the last 20
years, but morbidity rates remain high at 30–50%.1–3 One of the
most common complications after PD is breakdown of the
pancreatico-digestive anastomosis, which leads to pancreatic
fistula (PF). This can cause other major complications, such as
haemorrhage, intra-abdominal abscess, bile leak, wound infection
and cardiac failure,4 mainly because of the highly erosive nature of
the pancreatic fluid. Mortality in patients with PF is reported to
range from 0% to 40%.2,4–9 Although the majority of patients with
PF can be managed conservatively with medical and radiological
therapy, re-laparotomy may be required for PF compli-
cated by peritonitis, intra-abdominal abscess or uncontrolled
haemorrhage.10–12 Early diagnosis and appropriate management of
postoperative complications are essential to improve surgical
results. Outcomes depend on the ability to control the source of
sepsis or bleeding. One way to improve prognosis in patients with
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life-threatening complications, such as peritonitis or uncontrolled
haemorrhage secondary to PF after PD, is by wirsungostomy,
which refers to the complete external catheter drainage of the
remaining pancreatic duct after a specific procedure performed to
control sepsis or haemorrhage. This study reports a single-centre
experience of wirsungostomy used as an alternative to completion
pancreatectomy. The study centre performs a high number of
pancreatic resections.
Materials and methods
From January 2004 to April 2011, patients who underwent PD at
Haut-Lévêque Hospital, University of Bordeaux Hospital Centre
(Centre Hospitalier Universitaire de Bordeaux) were retrospec-
tively identified from the PD database. Patients were included for
further study if they had undergone wirsungostomy for PF.
Data analysed for wirsungostomy patients included the postop-
erative interval between PD and re-laparotomy, the grade and type
of complications associated with PF, and surgical parameters such
as operative time and amount of bleeding during re-laparotomy.
Main outcome measures such as mortality, morbidity and long-
term outcome were assessed by interview.
Pancreatic fistulae were identified by the presence of amylase-
rich fluid of more than three times the serum concentration
collected from postoperative day 3 from the drain placed
intraoperatively in the abdomen, in accordance with criteria
defined by the International Study Group on Pancreatic Fistula
(ISGPF).13
Haemorrhage was defined according to ISGPF criteria14 by
three parameters, including onset, location and severity. Early
haemorrhage occurred at24 h after the end of the index opera-
tion. The location was either intraluminal or extraluminal. Severe
haemorrhage was defined by a drop in haemoglobin level of3 g/
dl, or by clinically significant impairment (e.g. tachycardia,
hypotension, oliguria, hypovolaemic shock) requiring blood
transfusion, or by the need for invasive treatment (angiographic
embolization or re-laparotomy). According to these three param-
eters, haemorrhages were classified as Grade A, B or C.
Sepsis was defined by the presence of both infection and sys-
temic inflammatory response. Septic shock was defined as severe
sepsis (sepsis complicated by organ dysfunction) plus a state of
acute circulatory failure characterized by persistent arterial
hypotension despite adequate fluid resuscitation.15
Postoperative peritonitis was suspected according to the pre-
sentation of clinical symptoms such as peritoneal tenderness,
abdominal pain and fever of >38.5 °C, and was confirmed at
surgery.
Intra-abdominal collection was diagnosed by a computed
tomography (CT) scan, which was performed in patients in whom
the postoperative course was complicated.
Delayed gastric emptying (DGE) was defined as the inability to
return to a standard diet by the end of the first postoperative week
and included prolonged nasogastric intubation of the patient
according to the International Study Group of Pancreatic Surgery
(ISGPS) definition.16
Postoperative complications were retrospectively classified
according to the system of Clavien and colleagues for each
patient.1,7
Surgical procedure
The surgical procedure at re-laparotomy included complete
exploration and lavage of the abdominal cavity, eradication of all
sources of infection and drainage of dependent areas, debride-
ment of necrotic tissues and the establishment of haemostasis by
the elective ligature of the source of bleeding.
The pancreatico-digestive anastomosis was dismantled. The
jejunal stump was closed using a GIA® stapler. An overcast stitch
using a PDS® 4/0 suture was used to secure haemostasis. The
proximal third of the remaining pancreatic duct was then canu-
lated with a thin polyethylene tube with lateral holes at one end
(Escat drain) in order to enable better pancreatic fluid drainage.
The catheter was then stitched to the pancreatic remnant with a
PDS® 5/0 suture by two U-shaped interrupted sutures, and the
free end was passed through the abdominal wall and stitched to
the skin as a controlled pancreaticocutaneous fistula. Two silicone
drains were placed; one of these was positioned behind the
hepatico-digestive anastomosis and passed through the right side
of the abdominal wall, and the other was placed close to the
pancreatic remnant and passed through the left side of the
abdominal wall. In some patients a Witzel feeding jejunostomy
was performed in the jejunal loop immediately distal to the gas-
troenterostomy. The abdominal wall was closed in a conventional
manner.
Postoperative evaluation of leucocytosis, C-reactive protein
(CRP) and glycaemia was systematically performed during hospi-
talization. No patient received medication to decrease digestive or
pancreatic secretion. Parenteral nutrition was started as soon as
possible and replaced by enteral or oral feeding once the gas-
trointestinal ileus had resolved. The silicone drains placed in the
abdominal cavity were removed when output reduced to <30 ml.
Patients in whom output via the Escat tube persisted after a few
months required an injection of coil (Neoprene®) into the drain.
The pancreatic exocrine insufficiency induced was treated with
oral pancreatic enzyme when feeding started.
Results
Of the 244 patients who underwent PD, 62 (25.4%) had a PF. A
total of 41 patients (66.1%) with PF of Grades A and B were
managed conservatively, whereas 21 patients (33.9%) with Grade
C PF required re-laparotomy for wirsungostomy (n = 19) or
completion pancreatectomy (n = 2). Two other patients were
transferred from another hospital with Grade C PF that required
re-laparotomy for wirsungostomy. Completion pancreatectomy
was performed for massive haemorrhage in two patients at the
beginning of the series. These two patients were not included for
further analysis.
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The 21 patients who underwent wirsungostomy included 18
men and three women. Their median age was 66 years (range:
48–78 years). Medical comorbidities, defined according to Ameri-
can Society of Anesthesiologists (ASA) scores and indications for
PD, are shown in Table 1. Pancreaticoduodenectomy was per-
formed in all patients and was reconstructed with either a pan-
creaticojejunal (n = 20) or pancreaticogastric (n = 1) anastomosis.
In the initial postoperative course, 15 patients were diagnosed
with Grade C PF. Fluid drainage in six patients was poor in
amylase and PF was diagnosed during re-laparotomy. The median
time between the initial operation and re-laparotomy was 9 days
(range: 2–21 days). All reoperations were performed as emergency
procedures.
Patients were reoperated for haemorrhage (n = 12) externalized
through the abdominal drain (n = 7) or into the gastrointestinal
tract (n = 2) and classified as Grade B (n = 1) or C (n = 11),
peritonitis (n = 4), septic shock (n = 4) or mesenteric ischaemia (n
= 1). Haemorrhage for the other three patients was not external-
ized. The reoperation rate in patients with PF was 33.9% (21 of 62
patients), whereas the overall reoperation rate was 8.6% (21 of 244
patients). In this series, the only cause of reoperation was PF with
health-threatening complications. No patients were reoperated
for other causes. Haemorrhage occurred in 15 of 62 (24.2%) cases
of PF. The overall bleeding rate after PD in this series was 6.1% (15
of 244 patients). Patients with haemorrhage required wirsungos-
tomy (n = 12), completion pancreatectomy (n = 2) and radiologic
embolization (n = 1). No haemorrhage occurred without PF. Of
the patients who underwent wirsungostomy, 11 had delayed
haemorrhages and one had an early haemorrhage. No patient had
a sentinel bleed before the haemorrhage requiring re-laparotomy.
All patients required intensive care unit (ICU) treatment for life-
threatening complications. Ten patients suffered single-organ
dysfunction of Grade IVa and four patients suffered multi-organ
dysfunction of Grade IVb.
Operative characteristics of wirsungostomy
The median operative time was 120 min (range: 60–200 min). The
median operative blood loss was 790 ml (range: 100–2000 ml).
The median transfusion of packed red blood cells required was 2.3
units (range: 0–6 units). Haemorrhage originated from erosion of
the hepatic artery (n = 4), the splenic artery (n = 1), the stump of
the gastroduodenal artery (n = 1), and from the cut surface of the
pancreatic remnant (n = 3). Three patients showed no active
bleeding during the procedure.
Postoperative course after wirsungostomy
Six patients died in the early postoperative period. Three patients
who required ligation of the hepatic artery for haemostasis sec-
ondary to hepatic artery erosion died of hepatic failure within 3
days postoperatively. Two patients died of refractory septic shock.
The last patient died after reoperation for extensive mesenteric
ischaemia. The mortality rate of patients with PF was 9.7% (six of
62 patients). Postoperative mortality rates were 19.0% (four of 21
patients) after haemorrhage and 9.5% (two of 21 patients) after
peritonitis or septic shock.
Nine patients suffered a combined total of 16 postoperative
complications. These included acute kidney failure (in four
patients, two of whom required haemofiltration), DGE (in three
patients), fistula of the biliodigestive anastomosis (in one
patient), pleural effusion (in three patients, two of whom
required percutaneous drainage), pneumonia (in one patient),
intrahepatic abscess (in one patient with ligation of hepatic
artery), abscess of the abdominal wall (in two patients) and
re-laparotomy to reposition the catheter of the remaining
pancreatic duct (in one patient). Six complications were
classified as Grade IIIa, one as Grade IIIb and nine as Grade II.
The median length of hospital stay of survivors was 42 days
(range: 34–60 days).
Longterm follow-up
Fifteen patients were available for longterm follow-up. Nine
patients developed a pancreatic pseudocyst during the follow-up,
but only three of them required analgesic therapy. None required
percutaneous or transgastric drainage.
The median time to Escat drain removal was 4 months (range:
2–11 months). During follow-up the drains in two patients were
found to be blocked and required a 2-ml injection of serum. Two
patients required an injection of coil (Neoprene®) into the drain
before removal because drain output of <5 ml persisted.
Three patients developed postoperative diabetes mellitus (DM)
requiring insulin therapy. All patients required oral pancreatic
enzyme replacement therapy.
Table 1 Patient characteristics
Characteristic n %
American Society of Anaesthesiologist
(ASA) score
21
1 5 23.8
2 12 57.2
3 4 19.0
Indication for duodenopancreatectomy 21
Adenocarcinoma of the pancreas 9 42.8
Adenocarcinoma of the ampulla 4 19.0
Adenocarcinoma of the duodenum 1 4.8
Neuroendocrine neoplasm 3 14.2
Intraductal papillary mucinous
neoplasm of the pancreas
1 4.8
Cholangiocarcinoma 1 4.8
Gastrointestinal stromal tumour of the
duodenum
1 4.8
Metastasis of colonic cancer 1 4.8
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Three patients received adjuvant chemotherapy. Six patients
developed disease recurrence. Four of these six patients died
within 7, 8, 9 and 15 months, respectively, of the PD.
Discussion
The safety of a pancreatico-digestive anastomosis is closely
related to the texture of the pancreatic remnant, which is the
main determining factor of PF after PD.4,17–21 Rates of PF after PD
are strictly dependent upon the definitions used. Prior to the
ISGPF definition,13 Bassi et al.22 reported incidences of PF as
ranging from 9.9% to 28.5% according to the various definitions
of PF. In most patients, PF was not symptomatic and was diag-
nosed biochemically. However, pancreatic anastomotic break-
down can lead to haemorrhage, peritonitis, sepsis and abscess
development and requires re-intervention in 10–15% of
patients.6,17,23–25 This results in a subsequent increase in mortality
after PD.2,3,6,12 Although some studies6,17,23,25,26 have shown signifi-
cant reductions in overall rates of re-laparotomy, indicating that
many complications can be managed by non-operative means,
the same studies reported that around 15–50% of patients
required surgical intervention after radiological drainage. In the
present study, the reoperation rate for PF was 33.9% (overall
reoperation rate: 8.6%) and the mortality rate of patients with PF
was 9.7% (overall mortality: 2.4%); this compares with rates of
0–40% reported in the literature.2,4–9
Massive haemorrhage is the most critical complication of PF
after PD and is associated with high mortality.12,27,28 Delayed
haemorrhage either originates from the gastrointestinal tract as a
result of ulceration at an anastomosis or occurs intra-abdominally
as a result of pseudoaneurysm secondary to PF.12,27–29 Blanc et al.12
reported haemorrhage after PD in 27 of 411 patients (6.6%), in
only two of whom (7.4%) conservative treatment including coil
embolization and exclusion by covered stent was performed (one
patient had sentinel bleeding and one demonstrated an isolated
fall in haemoglobin level). Angiographic embolization is most
useful in patients with sentinel bleeding before massive haemor-
rhage and haemodynamic instability occur. Patients with PF often
require reoperation when haemorrhage occurs.12,24,27,28 In the
present study, the prevalence of massive and life-threatening
haemorrhage was 4.9% (n = 12), which is in keeping with a rate of
post-PD haemorrhage of 5.7% reported in the literature.30 Four
patients required ligation of the hepatic artery and three of these
patients died secondary to liver failure caused either by ischaemia
of the biliary tree or by fatal recurrent liver abscesses.8 Haemody-
namic instability precluded the administration of endovascular
treatment with coil embolization or covered stent in all of these
four patients.
When reoperation is required to control massive delayed
haemorrhage or sepsis, many surgical procedures can be per-
formed. These include completion pancreatectomy, which is
often recommended,6,10–12,31–33 and the dismantling of the
pancreatico-digestive anastomosis and preservation of the pan-
creatic tail with closure12,33 or with external catheter drainage of
the pancreatic duct remnant.27 Other than the study by de Castro
et al.,33 which reported no deaths in a series of nine completion
pancreatectomies, and a study conducted by Farley et al.,32 which
reported a 24% mortality rate, this procedure is associated with
high mortality rates of 38–71%.6,10,11,31 Tissues in the surgical
pancreatic field are very inflamed and are haemorrhagic and
fragile. Surgical exploration and the identification of the bleeding
vessel related to a PF may be difficult. In these circumstances,
completion pancreatectomy is technically demanding and poten-
tially hazardous, and involves a mean operative time of around
160 min and a mean operative blood loss of around 1800 ml.32 In
the present study, the median operative time was 105 min and
the median operative blood loss was 700 ml. A recent review of
the literature on abdominal trauma recommended that surgeons
should avoid extensive procedures in unstable patients.34 Early
control of bleeding achieved by a short operative procedure helps
to prevent heat loss, acidosis and coagulopathy in patients who
require ICU care. In the present study, patients with life-
threatening haemorrhage required the same approach. An earlier
study27 reported the use of external pancreatic duct drainage as a
salvage procedure for massive haemorrhage related to PF after
PD. Mortality following external pancreatic duct drainage in this
study occurred in four of seven patients (57.1%),27 whereas in the
present study death occurred in six of 21 patients (28.6%). Fur-
thermore, completion pancreatectomy induces unstable DM,
which is associated with severe hypoglycaemic events and recur-
rent infections which alter the patient’s quality of life.10,32,35,36
Some authors36,37 have shown that postoperative diabetes can be
avoided if 5 cm of pancreatic remnant can be preserved to allow
the persistence of Langerhans cells in the pancreatic parenchyma.
In the present study, only three of 15 patients developed DM
during longterm follow-up and all DM was well controlled with
insulin therapy.
The controlled pancreaticocutaneous fistula, achieved by wir-
sungostomy, healed spontaneously in the majority of patients in
the present study. Only two patients required coil injection to stop
the output of the wirsungostomy. In all the other patients the
output of the wirsungostomy stopped spontaneously. Nine
patients developed a pancreatic pseudocyst after wirsungostomy,
but only three required analgesic therapy and none required
pseudocyst drainage. The drained pancreatic stump can become
fibrotic with pancreatic duct distension. In the event of symptom-
atic pseudocyst, transgastric drainage is preferable to percutane-
ous drainage.
Although it is difficult to make comparisons among a small
number of patients, these data suggest that preservation of the
pancreatic remnant using wirsungostomy has a role in the man-
agement of patients with uncontrolled haemorrhage or peritonitis
after PF.
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